D Raeside, A Peacock
Primary pulmonary hypertension is a well known though in patients with persistent hypoxaemia (Pa 2 <7.3 kPa) who complain of deteriorating exercise tolerance in the rare condition, but pulmonary hypertension also occurs as a consequence of most heart and lung diseases where it is face of static spirometric values, or in those who develop evidence of fluid retention. This can be a difficult clinical largely unrecognised and untreated and is therefore a major clinical challenge. The consequence of this failure to assess diagnosis and one American study noted that up to 30% of admissions to hospital with a diagnosis of congestive the pulmonary circulation is that the process may progress to the point where treatment is less likely to be beneficial.
cardiac failure actually had fluid retention associated with pulmonary hypertension. 4 It is because the symptoms and signs of pulmonary hypertension are often rather vague and non-specific that it There is little doubt that secondary pulmonary hypertension is an important factor in the morbidity and is important to be aware of methods of measurement in the pulmonary circulation and their sensitivity, specificity, mortality of chronic hypoxic lung disease and other conditions. Quantifying pulmonary haemodynamics should be and relative merits. There is no easily applied sphygmomanometer for the pulmonary circulation, but there are a an important part of assessment of these patients and can assist us in future decisions about the success or otherwise number of techniques -both invasive and non-invasivewhich can help us to make the diagnosis. Implicit in the of treatment directed both at the primary respiratory disease and at the pulmonary circulation itself. Clearly, the first desire to make an earlier diagnosis of pulmonary hypertension is the belief that there is some point in doing therapeutic objective must be the treatment of the pulmonary condition, 5 but we should be monitoring the effects so -that is, that the condition is itself of significance and that we may be able to offer some additional treatment to of this treatment and the use of vasodilators, if appropriate, on the pulmonary circulation.
6 the patient.
   When to consider secondary pulmonary
This diagnosis should always be considered in a patient hypertension?
with a past history of deep venous thrombosis or pulmonary The causes of secondary pulmonary hypertension are: (1) embolus who subsequently develops unexplained sympchronic hypoxic lung disease including chronic airflow toms of breathlessness. Where the patient presents soon obstruction, fibrosing lung disease, and ventilatory failure after the event the diagnosis may seem obvious, but Moser 7 due to primary chest wall dysfunction; (2) thromboembolic has described the "honeymoon period" after pulmonary pulmonary hypertension; and (3) connective tissue disease, embolism where the patient's symptoms can improve for especially CREST syndrome. a period of months or years before deteriorating again, sometimes rapidly. Significantly, his group estimated that between 0.1% and 1.0% of all embolic patients go on     to develop thromboembolic pulmonary hypertension, and While a number of conditions can give rise to secondary that in nearly half the initial event was unrecognised. pulmonary hypertension, hypoxic lung disease is the one most commonly encountered in clinical practice. The extent of the problem is difficult to define and is further    complicated by the debate about the term "cor pulmonale" Pulmonary vasculitis is rare in most connective tissue which is often used when patients with respiratory failure disorders, being seen in <2% of patients with systemic develop oedema. This expression implies dysfunction of lupus erythematosus, but it is a serious complication. 8 In the heart when, in fact, the fluid retention is probably the CREST variant of systemic sclerosis severe pulmonary renal in origin, though is associated with the pulmonary hypertension is much more common and is the most hypertension. For this reason many authors would prefer important cause of mortality and morbidity in this conthat the term is no longer used and that it should be dition. Here the medium and small pulmonary arteries replaced with "fluid retention in association with secondary undergo pathological changes similar to those seen in pulmonary hypertension". 1 primary pulmonary hypertension. Patients may present There is controversy about the contribution of secondary with minimal or no clinical respiratory signs other than pulmonary hypertension to the mortality and morbidity of breathlessness, but a clue is a low carbon monoxide gas chronic hypoxic lung disease, but the important variations transfer factor in the face of normal spirometric values. in pulmonary artery pressure caused by exercise, sleep (due to alveolar hypoventilation), 2 and episodes of respiratory failure secondary to acute infection are now accepted, although the latter have been shown to return to normal How to measure the pulmonary circulation? -    before becoming resistant to treatment as the disease progresses.
3 Clearly these are difficult to measure routinely Traditional methods of assessment include tests which suggest the presence of pulmonary hypertension (clinical because of the difficulty in making reliable measurements of pulmonary haemodynamics repeatedly. The signs and examination, electrocardiography, chest radiography, and conventional echocardiography) and those which suggest symptoms of pulmonary hypertension are usually overwhelmed by those of chronic obstructive pulmonary disease a cause (pulmonary function tests, ventilation perfusion scanning, and arterial blood gas tensions).These have re-(COPD), but pulmonary hypertension should be suspected group.bmj.com on June 25, 2017 -Published by http://thorax.bmj.com/ Downloaded from cently been augmented by techniques which tell us about Continuous Doppler echocardiography has attained widespread use and recent data suggest that the error limits the severity of pulmonary hypertension, especially Doppler echocardiography which will be considered in more detail.
for Doppler TR derived pressure calculations are only 5-9 mm Hg. 15 The technique is well tolerated, safe, and reHowever, the traditional methods are still of value.
Radiological assessment of pulmonary artery diameter, peatable, but there are some disadvantages. In particular, it is difficult to recover a TR signal of sufficient quality in patients M mode echocardiography, and electrocardiography were compared in one study 9 and each was found to have a with COPD where success rates may be as low as 30%.
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There is no such difficulty in examining flow charhigh specificity for detection of pulmonary hypertension (particularly at higher levels of pulmonary hypertension) acteristics in the right ventricular outflow tract. The pulsed Doppler signal is directed at the pulmonary valve and two but were individually too insensitive to be useful for routine clinical screening; a normal test does not exclude pulimportant measurements are made -namely, acceleration time (AT) and right ventricular ejection time (ET). 17 AT monary hypertension. More recent work 10 has employed complex data analyses to assess the combined value of is defined as the time from the onset of ventricular ejection to the attainment of maximum flow velocity through the these tests, including forced expiratory volume in one second (FEV 1 ), arterial blood gas tensions, electropulmonary valve, and ET is defined as the interval between the beginning and end of flow in the right ventricular cardiography, pulmonary arterial dimension on chest radiography, M mode echocardiography, and myocardial outflow tract. These flows have characteristic pulsed wave Doppler velocity envelopes. Normal subjects have a smooth thallium scanning, and confirmed that this approach allows the prediction of the presence of pulmonary hypertension dome-shaped envelope while patients with pulmonary hypertension show a notched pattern caused by a shortened but gives no indication of the actual value of the pulmonary artery pressure.
AT followed by a second slower rise during deceleration.
AT and ET can therefore be used to demonstrate the Ventilation/perfusion lung scanning is widely used in the evaluation of patients with pulmonary hypertension, presence of pulmonary hypertension but, unlike continuous wave Doppler assessment of TR jet velocity, the calculation primarily to exclude thromboembolic disease and to assess the need for pulmonary angiography. Pulmonary function of underlying values of pulmonary artery pressure is poor.
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Intra and interobserver variability is slightly worse than tests may likewise point to an underlying cause for suspected pulmonary hypertension such as COPD. Furwith continuous wave Doppler and the technique is less sensitive to factors which induce acute changes in pulthermore, an isolated reduction in diffusing capacity may be a pointer to pulmonary hypertension in a breathless monary artery pressure. 19 However, compared with the success rate for continuous wave Doppler in COPD of patient with normal spirometric values.
approximately 30%, pulsed wave Doppler can detect pulmonary hypertension in over 90% of cases.   The techniques described above, most of which remain in     routine clinical use, can detect pulmonary hypertension Conventionally, fluid filled thermodilution catheters have but give no assessment of its severity. Hence, they cannot been taken as the gold standard against which other techbe used to follow the clinical course of patients with niques have been compared, though this view is not acpulmonary hypertension or assess the benefits of intercepted by some authors. 20 Right heart catheterisation is vention.
usually carried out using a fluid filled thermodilution cathIn 1984 Yock and Popp 11 described a technique which eter of the Swan Ganz type. 21 The procedure can be used allowed estimation of pulmonary arterial pressure from the to answer a number of questions and is very fully described measurement of the maximum velocity of the regurgitant elsewhere 22 but, essentially, the catheter is inserted via a jet in patients with tricuspid regurgitation (TR). When TR central vein and advanced until the tip is placed in the is present the velocity of the regurgitant jet is determined pulmonary artery. Position can be determined either from solely by the pressure difference between the right ventricle the pressure trace or by direct screening with fluoroscopy. (RV) and the right atrium (RA) and not by the geometry
The catheter has two fluid filled lumina from which presof the orifice. To make this estimate the TR jet is identified sure traces of right atrial and pulmonary artery pressures and located using pulsed or colour Doppler before conare recorded simultaneously by external transducers, and tinuous wave Doppler recordings are made to determine a thermistor for measurement of pulmonary blood flow by peak TR jet velocity. Providing that the angle between the the thermodilution technique. Pressure measurements are ultrasound beam and the direction of flow is less than 20 conventionally made in the right atrium, right ventricle, degrees, velocity of flow can be calculated accurately. This pulmonary artery, and in the wedge position to record maximum velocity can then be used in a modified form of pulmonary artery occlusion pressure which is an estimate the Bernouilli equation which states that: of left atrial pressure. Pressure and flow measurements can RV to RA pressure gradient= be repeated following interventions such as the ad-4×(maximum velocity of TR jet) 2 ministration of vasodilators or oxygen, or after exercise. Thus, in addition to the direct measurement of pressures, The calculated gradient is added to the right atrial pressure (which can be estimated clinically) to give an a number of variables are derived which can be used to calculate further information such as pulmonary vascular estimated value of right ventricular systolic pressure. Assuming there is no pulmonary stenosis, which can be resistance (PVR) which is calculated by subtracting the pulmonary artery occlusion pressure (estimated left atrial excluded by echocardiography, this value will be equal to pulmonary arterial pressure. The authors have shown these pressure) from the mean pulmonary artery pressure and dividing by the cardiac output. This value of PVR (exvalues to correlate closely with those found at right heart catheterisation even when not measured simultaneously.
pressed in Wood's units) may be altered by the interventions mentioned above to give an idea of the vasoreactivity of This technique confers a number of advantages. The values obtained are accurate over a wide range of presthe pulmonary circulation.
As with the other investigative tools discussed so far there sures 12-14 and are not affected by changes in cardiac output. 12 Interobserver variability is <3%, 12 though clearly the are advantages and disadvantages to right heart catheterisation, but most important are the significant risks to technique is, to some extent, operator dependent.
group.bmj.com on June 25, 2017 -Published by http://thorax.bmj.com/ Downloaded from the patient ranging from the common and relatively trivial, continuous wave and pulsed wave Doppler. When pulmonary hypertension is confirmed, or where there continues such as self limiting ventricular arrhythmias, to the very to be any doubt, the patient should be referred to a pulrare but often fatal rupture of the pulmonary artery (risk monary vascular centre for further assessment. approximately 1/3000). 23 Apart from the risks, hospital admission is usual which may be inconvenient for patients. with the pressure transducer connected to an in vivo 
